World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $875.81bn | 71.54 | 0.53% |
NOVO BNovo Nordisk A/S | DKK3.75tn | 40.29 | 1.16% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $395.17bn | 19 | 2.93% |
ABBVAbbvie | $341.73bn | 38.41 | 3.13% |
MRKMerck & Co | $297.00bn | 14.02 | 2.59% |
ROGRoche Holding AG | CH₣213.14bn | 14.56 | 3.59% |
RORoche Holding AG | CH₣213.14bn | 15.58 | 3.35% |
AZNAstraZeneca | £182.62bn | 37.52 | 1.89% |
NOVNNovartis AG | CH₣199.30bn | 19.06 | 3.39% |
AMGNAmgen | $181.28bn | 60.92 | 2.6% |
PFEPfizer | $166.71bn | 10.83 | 5.64% |
SANSanofi SA | €129.53bn | 19.56 | 3.63% |
GILDGilead Sciences | $104.50bn | 12.03 | 3.62% |
CELG RTBristol-Myers Squibb Co | $100.17bn | 0.01 | 6685.71% |
BMYBristol-Myers Squibb Co | $100.17bn | 13.21 | 4.74% |
CSLCSL | AU$141.90bn | 36.75 | 1.32% |
ZTSZoetis | $87.28bn | 34.77 | 0.84% |
GSKGSK | £63.67bn | 10.83 | 3.91% |
4519Chugai Pharmaceutical Co | ¥11tn | 31.72 | 1.18% |